Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FP30K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,768
Award facts
- Contract value 100% obligated
- $41,767.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,767.86 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors, with an ultimate completion date of June 30, 2025. This non-competitive, firm fixed-price delivery order was issued on June 27, 2025, and represents a single-transaction procurement from the company's corporate office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99M global pharmaceutical support vehicle that runs through December 2026 and authorizes the company to supply a comprehensive range of medications, vaccines, and medical supplies to military and federal healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders through its prime IDC with DLA for diverse therapeutic areas including diabetes medications, neurological treatments, and specialty pharmaceuticals. This particular order for Zepbound, a GLP-1 receptor agonist used in weight management treatment, aligns with the company's established portfolio of brand-name pharmaceutical deliveries to support Defense Health Agency and other federal healthcare programs. The delivery order structure and firm fixed pricing reflect standard DLA procurement practices for pharmaceutical commodities, enabling efficient fulfillment of federal medical supply requirements across the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FP30K?
SPE2DB25FP30K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 27, 2025.
How much is contract SPE2DB25FP30K worth?
The government has obligated $41,768 on SPE2DB25FP30K.
Is contract SPE2DB25FP30K an order under another contract?
Yes. SPE2DB25FP30K is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP30K competed?
The extent of competition for SPE2DB25FP30K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award